Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,667,933 papers from all fields of science
Search
Sign In
Create Free Account
mepirodipine
Known as:
1-benzyl-3-pyrrolidinyl methyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
, Barnidipine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Narrower (3)
BARNIDIPINE HCL
Cyress
YM 09730
Broader (2)
Calcium Channel Blockers
Nifedipine
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus
G. Derosa
,
F. Querci
,
I. Franzetti
,
P. D. Ragonesi
,
A. D'Angelo
,
P. Maffioli
Hypertension Research
2015
Corpus ID: 24195998
The aim of this study was to evaluate the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on…
Expand
2009
2009
Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
T. Furukawa
,
T. Nukada
,
+5 authors
T. Isshiki
European Journal of Pharmacology
2009
Corpus ID: 34169745
Review
2005
Review
2005
Barnidipine: a new calcium channel blocker for hypertension treatment
C. Liau
Expert Review of Cardiovascular Therapy
2005
Corpus ID: 20724880
Although it is commonly agreed that all antihypertensive medications have similar efficacy, there are important differences…
Expand
2001
2001
Preferential renal and mesenteric vasodilation induced by barnidipine and amlodipine in spontaneously hypertensive rats
B. Janssen
,
K. Kam
,
J. Smits
Naunyn-Schmiedeberg's Archives of Pharmacology
2001
Corpus ID: 7524438
Abstract. Barnidipine is a stereoselective single isomer formulation of a long-term acting dihydropyridine calcium antagonist…
Expand
Review
1998
Review
1998
The pharmacological properties of lipophilic calcium antagonists.
P. V. van Zwieten
Blood pressure. Supplement
1998
Corpus ID: 43209308
Several types of calcium antagonists (CA) (verapamil, diltiazem, nifedipine and related drugs) may be used as antihypertensives…
Expand
1998
1998
The role of combination therapy in the treatment of hypertension.
L. Ruilope
,
A. Coca
Blood pressure. Supplement
1998
Corpus ID: 21829100
Antihypertensive therapy is indicated for reducing the risk of cardiovascular morbidity and mortality that accompanies arterial…
Expand
1998
1998
Differential time course of the vasodilator action of various calcium antagonists
R. Lee
,
K. Kam
,
M. Pfaffendorf
,
P. Zwieten
Fundamental & Clinical Pharmacology
1998
Corpus ID: 27406772
Summary— It is rather the rate of the vasodilator effect than its magnitude which determines the triggering of reflex tachycardia…
Expand
1998
1998
Effect of the Vasodilatory β-Blocker, Nipradilol, and Ca-Antagonist, Barnidipine, on Insulin Sensitivity in Patients with Essential Hypertension
I. Kosegawa
,
M. Inaba
,
T. Morita
,
T. Awata
,
S. Katayamá
1998
Corpus ID: 73946479
Objectives To assess the effects of a vasodilatory β -adrenoceptor blocker, nipradilol, and a long-acting Ca channel blocker…
Expand
1998
1998
Efficacy and tolerability of once-daily barnidipine in the clinical management of patients with mild to moderate essential hypertension.
C. Spieker
Blood pressure. Supplement
1998
Corpus ID: 25366363
Four multicentre trials have investigated the efficacy and tolerability of treatment with once-daily, modified-release capsules…
Expand
1995
1995
Effects of calcium channel antagonists on the induction of nitric oxide synthase in cultured cells by immunostimulants.
Y. Hattori
,
K. Kasai
,
S. So
,
S. Hattori
,
N. Banba
,
S. Shimoda
Life Science
1995
Corpus ID: 23254986
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE